Nigel Fleeman
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Schizophrenia research and treatment
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 5
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Y Dündar (36 shared papers)Angela Boland (34 shared papers)Peter Bradley (4 shared papers)A Bagust (23 shared papers)Rumona Dickson (18 shared papers)Bruce Lindsay (2 shared papers)C McLeod (12 shared papers)J Greenhalgh (17 shared papers)
- Journals
- Health Technology Assessment (20 papers)Cochrane Database of Systematic Reviews (10 papers)PharmacoEconomics (5 papers)Environmental Research Letters (2 papers)The Lancet Respiratory Medicine (1 paper)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Nigel Fleeman
56 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 114
- Pharmacology 129
- Psychiatry and Mental health 172
- Genetics 92
- Otorhinolaryngology 35
- Pulmonary and Respiratory Medicine 182
Countries citing papers authored by Nigel Fleeman
This map shows the geographic impact of Nigel Fleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Fleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Fleeman more than expected).
Fields of papers citing papers by Nigel Fleeman
This network shows the impact of papers produced by Nigel Fleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Fleeman. The network helps show where Nigel Fleeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel Fleeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 97 | |
| 2 | 2010 | 88 | |
| 3 | 2008 | 66 | |
| 4 | 2015 | 56 | |
| 5 | 2010 | 53 | |
| 6 | 2011 | 50 | |
| 7 | 2009 | 48 | |
| 8 | 2009 | 47 | |
| 9 | 2021 | 47 | |
| 10 | 2009 | 46 | |
| 11 | 2011 | 41 | |
| 12 | 2019 | 37 | |
| 13 | 2024 | 37 | |
| 14 | 2010 | 36 | |
| 15 | 2015 | 35 | |
| 16 | 2020 | 32 | |
| 17 | 2015 | 31 | |
| 18 | 2012 | 31 | |
| 19 | 2016 | 28 | |
| 20 | 2010 | 26 |
About Nigel Fleeman
Nigel Fleeman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology, having authored 61 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Epilepsy research and treatment (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers), Breast Cancer Treatment Studies (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Energy and Environment Impacts (4 papers). The work is most often cited by research in Pharmacology (129 citations), Psychiatry and Mental health (172 citations), Genetics (92 citations), Otorhinolaryngology (35 citations) and Pulmonary and Respiratory Medicine (182 citations). Nigel Fleeman has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Y Dündar, Angela Boland, Peter Bradley, A Bagust, Rumona Dickson, Bruce Lindsay, C McLeod, J Greenhalgh, Sophie Beale and T Walley. Their work appears in journals such as Health Technology Assessment, Cochrane Database of Systematic Reviews, PharmacoEconomics, Environmental Research Letters and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.